10 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34328253 | In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel. | 2021 Nov | 3 |
2 | 34909672 | Pharmacokinetic drug interactions of integrase strand transfer inhibitors. | 2021 | 1 |
3 | 32011683 | Genetic influence of ABCG2, UGT1A1 and NR1I2 on dolutegravir plasma pharmacokinetics. | 2020 May 1 | 2 |
4 | 28915895 | Impact of UGT1A1 gene polymorphisms on plasma dolutegravir trough concentrations and neuropsychiatric adverse events in Japanese individuals infected with HIV-1. | 2017 Sep 16 | 4 |
5 | 26898568 | Effect of carbamazepine on dolutegravir pharmacokinetics and dosing recommendation. | 2016 Jun | 2 |
6 | 25733917 | The role of dolutegravir in the management of HIV infection. | 2015 | 1 |
7 | 25845873 | Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy. | 2015 | 1 |
8 | 25858605 | [Mechanisms of action, pharmacology and interactions of dolutegravir]. | 2015 Mar | 1 |
9 | 24096683 | Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment. | 2014 Jan | 2 |
10 | 23824675 | Clinical pharmacokinetic, pharmacodynamic and drug-interaction profile of the integrase inhibitor dolutegravir. | 2013 Nov | 1 |